Connecticut House Bill HB05640

Connecticut 2013 Regular Session

• Introduced: 1/23/13
• Refer: 1/23/13

Caption

An Act Concerning The Use Of Step Therapy For And Off-label Prescribing Of Prescription Drugs By Insurance Companies.

Impact

If passed, HB 05640 would significantly impact current practices in the insurance industry, addressing the concerns of many advocates who argue that existing step therapy protocols can delay effective treatment for patients. By restricting insurance companies' authority to dictate drug prescriptions based solely on financial considerations, the bill stands to improve patient care and support physician autonomy. This change is expected to facilitate better health outcomes, as providers will have direct control over medication management without interference from insurers.

Summary

House Bill 05640 aims to reform the practices of insurance companies regarding prescription drugs, particularly focusing on step therapy and off-label prescribing. The bill proposes to prevent insurers from requiring that a specific drug be prescribed more than once before allowing a healthcare provider to choose a different medication for the insured. This legislative change seeks to empower healthcare providers and ensure that patients have greater access to suitable treatment options without unnecessary barriers imposed by insurance companies.

Contention

The main points of contention surrounding HB 05640 involve the balance between insurance cost management and patient care. Supporters of the bill argue that the current system creates unnecessary hurdles that prevent patients from accessing appropriate medications in a timely manner. Conversely, opponents might defend insurance companies' right to impose such requirements as a means of controlling costs and ensuring that prescribed medications are medically appropriate before exploring alternatives. The debate highlights ongoing tensions in healthcare regarding autonomy, cost-effectiveness, and patient rights.